Alpha 2.0
Login Register
» Authors » Christine Prosperi

Christine Prosperi

Explore the profile of Christine Prosperi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 915
Followers 0
Related Specialties
Infectious Diseases
Pediatrics
Public Health
Top 10 Co-Authors
Katherine L OBrien
Laura L Hammitt
Maria Deloria Knoll
David R Murdoch
Daniel R Feikin
Melissa M Higdon
Shabir A Madhi
Donald M Thea
W Abdullah Brooks
David P Moore
Published In
Clin Infect Dis
Pediatr Infect Dis J
PLoS One
Lancet Glob Health
PLOS Glob Public Health
Affiliations
Soon will be listed here.
Recent Articles
1.
Measles and rubella seroprevalence in adults using residual blood samples from health facilities and household serosurveys in Palghar District, Maharashtra, India, 2018 - 2019
Prosperi C, Hasan A, Winter A, Chaaithanya I, Salvi N, Chauhan S, et al.
Epidemiol Infect . 2024 Dec; 152():e161. PMID: 39639481
Residual blood specimens collected at health facilities may be a source of samples for serosurveys of adults, a population often neglected in community-based serosurveys. Anonymized residual blood specimens were collected...
2.
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India
Prosperi C, Hasan A, Winter A, Chaaithanya I, Salvi N, Sharma S, et al.
Epidemiol Infect . 2024 Nov; 152:e143. PMID: 39552145
Residual blood specimens provide a sample repository that could be analyzed to estimate and track changes in seroprevalence with fewer resources than household-based surveys. We conducted parallel facility and community-based...
3.
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience
Miyakawa R, Zhang H, Brooks W, Prosperi C, Baggett H, Feikin D, et al.
Clin Microbiol Infect . 2024 Nov; 31(3):441-450. PMID: 39489292
Objectives: After respiratory syncytial virus (RSV), human metapneumovirus (hMPV) was the second-ranked pathogen attributed to severe pneumonia in the PERCH study. We sought to characterize hMPV-positive cases in high-burden settings,...
4.
Adjusting mobile phone data to account for children's travel and the impact on measles dynamics in Zambia
Kostandova N, Prosperi C, Mutembo S, Nakazwe C, Namukoko H, Nachinga B, et al.
Am J Epidemiol . 2024 Aug; PMID: 39191642
Models of measles transmission can be used to identify areas of high risk to tailor immunization strategies. Estimates of spatial connectivity can be derived from data such as mobile phone...
5.
Feasibility and acceptability of collecting dried blood spots (DBS) from children after vaccination during supplementary immunization activities to estimate measles and rubella seroprevalence
Carcelen A, Prosperi C, Hamahuwa M, Kapungu K, Chongwe G, Mwansa F, et al.
PLOS Glob Public Health . 2024 Jun; 4(6):e0002985. PMID: 38941295
Nested serosurveys within routine service delivery platforms such as planned supplemental immunization activities (SIAs) provide an opportunity to collect information that can be used to answer valuable questions on the...
6.
Who is missed in a community-based survey: Assessment and implications of biases due to incomplete sampling frame in a community-based serosurvey, Choma and Ndola Districts, Zambia, 2022
Kostandova N, Mutembo S, Prosperi C, Mwansa F, Nakazwe C, Namukoko H, et al.
PLOS Glob Public Health . 2024 Apr; 4(4):e0003072. PMID: 38683820
Community-based serological studies are increasingly relied upon to measure disease burden, identify population immunity gaps, and guide control and elimination strategies; however, there is little understanding of the potential for...
7.
Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020
Thangaraj J, Prosperi C, Kumar M, Hasan A, Saravana Kumar V, Winter A, et al.
PLoS One . 2024 Mar; 19(3):e0297385. PMID: 38551928
Background: In alignment with the Measles and Rubella (MR) Strategic Elimination plan, India conducted a mass measles and rubella vaccination campaign across the country between 2017 and 2020 to provide...
8.
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management
Gallagher K, Awori J, Knoll M, Rhodes J, Higdon M, Hammitt L, et al.
PLoS One . 2024 Mar; 19(3):e0297159. PMID: 38466696
Introduction: In 2012, the World Health Organization revised treatment guidelines for childhood pneumonia with lower chest wall indrawing (LCWI) but no 'danger signs', to recommend home-based treatment. We analysed data...
9.
Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic
Yang Y, Kostandova N, Mwansa F, Nakazwe C, Namukoko H, Sakala C, et al.
Vaccines (Basel) . 2023 Mar; 11(3). PMID: 36992192
Background: Measles-rubella supplementary immunization activities (MR-SIAs) are conducted to address inequalities in coverage and fill population immunity gaps when routine immunization services fail to reach all children with two doses...
10.
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020
Murhekar M, Gupta N, Hasan A, Kumar M, Saravana Kumar V, Prosperi C, et al.
Lancet Glob Health . 2022 Oct; 10(11):e1655-e1664. PMID: 36240831
Background: India did phased measles-rubella supplementary immunisation activities (MR-SIAs; ie, mass-immunisation campaigns) targeting children aged 9 months to less than 15 years. We estimated measles-rubella seroprevalence before and after the...